Sequoia Capital, founded in 1972 and based in Menlo Park, California, is a prominent venture capital firm that invests in early to growth stage companies across various sectors, including technology, healthcare, financial services, and consumer services. The firm specializes in supporting startups and emerging growth companies, typically investing between $100,000 and $1 million in seed companies, $1 million to $10 million in early ventures, and $10 million to $100 million in growth investments. Sequoia Capital operates globally, with a presence in regions such as Israel, China, and Southeast Asia, and has built a diverse portfolio that includes notable companies like Airbnb, Alibaba, and JD.com. The firm emphasizes a partnership approach with entrepreneurs, leveraging decades of experience to guide them from initial concept through to public offering and beyond.
Spectrum Medical is a clinical mass spectrometry product platform that promotes clinical mass spectrometry detection technology to the general public. It has an experienced research and development, operations, and sales team, a standardized GMP production workshop, extensive experience in laboratory construction, and a mature laboratory management system. It provides with complete supporting kits in addition to mastering the core mass spectrometry hardware manufacturing technology and equipment integration development capabilities (maternal and child genetics, nutritional levels, therapeutic drug testing, metabolic monitoring, etc.).
DigitAlp is a scientific and technical innovation company devoted to increasing the value of clinical research by giving a fresh perspective-a one-stop digital solution for the whole clinical trial process centred on institutions. Their solution includes an institutional comprehensive management system, the trial electronic medical record system, the sponsor service system, and the subject recruitment and full-service system.
Our telemedicine platform aims to transform the way healthcare is accessed, offering patients the flexibility to connect with trusted healthcare providers anytime, anywhere. Through our intuitive interface and advanced video conferencing capabilities, we enable seamless communication and personalized care delivery.
Bioforany
Venture Round in 2022
Bioforany is a biocatalyst manufacturer specializing in biocatalysts development and sales. Bioforany supply's low-carbon products to consumers in the domains of pharmaceutical intermediates, traditional Chinese medicine decoction components, functional food, animal nutrition, daily chemical care, plant protection, and renewable materials.
Us2.ai is a Singapore-based company that develops artificial intelligence-driven software and digital tools specifically for echocardiography. The company offers online solutions that streamline access to results from echocardiogram analyses and heart ultrasounds. Its machine learning platform automates the traditionally manual process of measuring and interpreting echocardiograms, enhancing the efficiency of cardiovascular research and clinical trials. By providing AI-based decision support tools, Us2.ai aims to save physicians time, improve the accuracy of clinical trials for pharmaceutical companies, and assist in the detection of conditions that are often overlooked or difficult to diagnose in hospital settings.
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.
Shanghai Xisoft Technology Co., Ltd. specializes in the development of mobile applications and online solutions focused on hospital operation management. Founded in 2018 and headquartered in Shanghai, the company offers a range of products, including the Xisoft Hospital Operation Management System (HRP), which serves as an information-sharing platform for managing hospital resources. Additionally, the Xiaoxi Handheld HRP is a mobile application that consolidates various hospital functions, such as contact management, salary inquiries, project management, and conference coordination. The Xiyun Platform further enhances hospital management by providing data extraction and calculation services. With a growing presence through offices in multiple cities across China, XiSoft aims to improve the efficiency and effectiveness of hospital operations.
Kenko Health is focused on creating a health management organization that offers comprehensive healthcare financing services. The company provides all-inclusive individual healthcare plans designed to cover a wide range of medical expenses, including medicines, doctor fees, lab tests, mental health services, dental care, and outpatient hospital bills. By offering low monthly payment options, Kenko aims to make healthcare more affordable for its customers, delivering prepaid benefits and significant discounts on various medical services.
Clipboard Health is an online marketplace established in 2016 and based in San Francisco, California, that connects nursing staff with healthcare facilities for job placements. The platform allows nurses to easily search for jobs that match their qualifications and preferences, enabling them to apply with just one click. By offering a comprehensive database of nursing and allied health positions across the country, Clipboard Health streamlines the staffing process for medical systems and healthcare professionals alike. This approach ensures that patients receive timely and appropriate medical care by matching them with the right nursing staff.
Athelas, Inc. develops and manufactures an innovative in-home blood diagnostic device designed to monitor the immune system using just a drop of blood. Founded in 2016 and based in Mountain View, California, the company's portable optical unit analyzes blood cells and generates diagnostic reports. This technology assists healthcare providers in early identification of conditions such as leukemia, infections, and inflammatory diseases, allowing patients to monitor their immunity levels conveniently from home. Athelas operates as a subsidiary of MerLion Pharmaceuticals Pte. Ltd.
the first high-tech company in China to focus on the treatment of cerebrovascular disease, it has more than four years of product research and development, leading China's cerebrovascular disease intelligence in an all-around way. vertical field of diagnosis and treatment. It has become a well-known brain stroke intelligence diagnosis and treatment platform in China.
Smiles.ai leverages proprietary technology and expert healthcare professionals to provide access to high-quality and cost-effective dental care products and services.
Virtue Diagnostics (Suzhou) Co., Ltd. is an in vitro diagnostic company established in 2019 and headquartered in Suzhou, China, with a research and development office in Singapore. The company specializes in developing advanced diagnostic technologies aimed at infectious diseases, cancer, and chronic diseases. Its offerings include clinical mass spectrometry, multiplex immunohistochemistry for pathology-based cancer detection, and a molecular and immunoassay platform. Through these technologies, Virtue Diagnostics aims to enhance disease detection and management, contributing to improved healthcare outcomes.
Vico Medical, established in 2018 and based in Wuhan, China, specializes in the development and production of medical devices aimed at treating cardiovascular and cerebrovascular diseases. The company offers a range of products, including atrial shunts, puncture systems, and occluders for patent foramen ovale, along with delivery systems and other related devices. Vico Medical focuses on providing innovative intervention treatment solutions for structural cardiovascular issues, contributing to the reduction of stroke and heart-related disease incidents.
Pristyn Care is a healthcare startup focused on transforming day care procedures through advanced surgical care. Founded by former consultant surgeons from prestigious medical institutions and professionals from notable companies, Pristyn Care aims to streamline the patient experience by leveraging technology and innovative surgical techniques. The company offers a range of advanced laser surgeries in various specialties, including urology, proctology, ENT, gynecology, laparoscopy, and dermatology. By implementing efficient processes and utilizing cutting-edge advancements in healthcare, Pristyn Care seeks to enhance patient outcomes and facilitate quicker recovery times.
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.
SyMap Medical specializes in the development and manufacturing of advanced medical devices aimed at treating hypertension and other significant health conditions, including heart failure and arrhythmia. The company focuses on a proprietary catheter-based system for renal mapping and ablation, which utilizes radiofrequency ablation technology as its core platform. This innovative approach is designed for renal denervation therapy, allowing for targeted treatment of hypertension and potentially alleviating symptoms associated with severe asthma and refractory complex arrhythmia. Through its cutting-edge solutions, SyMap Medical aims to improve patient outcomes in the management of these critical diseases.
KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company offers a comprehensive range of biological heart valves, focusing on minimally invasive solutions that enhance patient outcomes. Utilizing cutting-edge technologies, including anti-calcification, dry presentation, and leaflet thinning, KingstronBio aims to deliver innovative and effective products to the medical community, thereby addressing critical needs in cardiovascular care.
Mosaic Wellness Pvt Ltd, founded in 2019 and based in Mumbai, India, operates a platform of digital-first health clinics aimed at enhancing the health and wellness of individuals. The company provides a range of health and wellness products through its online presence, focusing on personalized solutions for specific needs. Its brands, including ManMatters for men and BeBodywise for women, work collaboratively to promote a fulfilling and purposeful lifestyle. By addressing niche segments, Mosaic Wellness strives to empower individuals to lead healthier lives.
Edge Medical Robotics, Inc. is a company that specializes in designing and developing advanced surgical equipment. Founded on May 4, 2017, and based in Longgang, Shenzhen, China, the company is dedicated to researching and promoting cutting-edge medical technology. Its mission focuses on enhancing surgical safety and treatment efficacy, aiming to elevate the overall standards of healthcare. Through a commitment to excellence and precision in product development, Edge Medical Robotics strives to contribute positively to the improvement of social health outcomes.
Suzhou MagAssist Medical Technology Co., Ltd. is a Chinese company specializing in the development of short and medium-term in vitro ventricular assist devices, commonly referred to as in vitro artificial hearts. Founded in 2016 and based in Suzhou, the company aims to provide innovative solutions for patients experiencing severe cardiovascular conditions, including those recovering from cardiopulmonary bypass and acute illnesses such as fulminant myocarditis and cardiac arrest. MagAssist focuses on integrating advanced fluid mechanics and magnetic suspension technology into its products to enhance compatibility with various blood types, thereby improving patient recovery outcomes. The company is recognized for its homegrown artificial heart technology, backed by a team of experts with extensive experience in artificial heart research and development.
Cellular Biomedicine Group is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. It is the result of the acquisition, transfer, commercialization, and advancement of thirty years of research and human treatment experience in cellular medicine. Its cellular research and development is the result of collaboration among scientists and doctors from the US, England, and China.
Maven Clinic operates an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and postpartum stages. The clinic provides access to video appointments and private messaging with a network of women's and family health practitioners. Its services cover various needs, including IVF, egg freezing, pregnancy, postpartum support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and tailored training for human resources. The company serves individuals, employers, and healthcare professionals, aiming to enhance healthcare experiences and outcomes for families. Founded in 2014 and headquartered in New York City, Maven Clinic is dedicated to delivering accessible and comprehensive care solutions.
Miaoshou Doctor is a healthcare service platform founded in 2015 by Tao He and Daoliang Han, based in Beijing. The platform facilitates communication between healthcare professionals and patients, focusing on the management of post-diagnosis outcomes. It enables doctors to actively follow up with patients through additional counseling and prescriptions, enhancing the overall patient care experience. By providing tools for effective interaction, Miaoshou Doctor aims to improve health management for both patients and doctors.
Joyo Pharma
Series B in 2021
Joyo Pharma focuses on the research and development of drugs for the treatment of tumors, autoimmunity, metabolism, and infectious diseases.
Eighteeth focuses on the research and production of dental instruments. Eighteeth has 14 product categories including endo motor, apex locator, ultrasonic scaler, curing light, X-Ray unit, intraoral sensor, intraoral scanner, and owns 110 authorized patents.
dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.
MoonBiotech is a Guangzhou-based healthcare startup that focuses on the development and research of microbe-based bioactive products for diverse applications. The company specializes in creating and screening high-quality microbial ingredients and fermentation products, catering to the needs of various industries such as biological agriculture, environmental governance, health food, and biomedicine. By providing valuable microbiological resources, MoonBiotech aims to address the increasing demand for innovative solutions in these sectors.
InSilico Medicine, Inc. is an artificial intelligence company focused on drug discovery, biomarker development, and aging research. Founded in 2014 and headquartered in Baltimore, Maryland, the company employs advanced AI technologies, including deep learning and generative adversarial networks, to create novel molecular structures for diseases with known and unknown targets. Its comprehensive platform covers all stages of drug development, from discovery to clinical trials. Key initiatives include Pharma.AI, which offers machine learning services to various industries, and Young.AI, which predicts biological age. InSilico Medicine also engages in internal drug discovery programs targeting conditions such as cancer, Parkinson's Disease, and age-related disorders. Additionally, the company has partnered with Life Extension to develop nutraceutical products using its bioinformatics and deep learning techniques. Through its innovative solutions, InSilico Medicine aims to enhance personalized healthcare and mitigate the effects of aging.
HiFiBiO is a biotherapeutics company focused on harnessing the human immune system to address diseases, particularly cancer and autoimmune disorders. Founded in 2013 and based in Paris, the company specializes in proprietary single-cell technologies that facilitate drug and biomarker discovery and development. HiFiBiO's platform combines extensive biological knowledge with advanced single-cell profiling techniques, allowing for the rapid identification and advancement of antibody drugs. Through partnerships with both industry and academic institutions, HiFiBiO aims to promote open innovation and enhance patient outcomes by unlocking the therapeutic potential of the immune system.
Shanghai Xisoft Technology Co., Ltd. specializes in the development of mobile applications and online solutions focused on hospital operation management. Founded in 2018 and headquartered in Shanghai, the company offers a range of products, including the Xisoft Hospital Operation Management System (HRP), which serves as an information-sharing platform for managing hospital resources. Additionally, the Xiaoxi Handheld HRP is a mobile application that consolidates various hospital functions, such as contact management, salary inquiries, project management, and conference coordination. The Xiyun Platform further enhances hospital management by providing data extraction and calculation services. With a growing presence through offices in multiple cities across China, XiSoft aims to improve the efficiency and effectiveness of hospital operations.
DeepScribe is bringing the joy of care back to medicine with its artificially intelligent medical scribe. Imagine a world where you visit your patients and come back to your desk to see the entire appointment accurately documented for you in your Electronic Health Record (EHR) System. No frustrating voice dictation services. No expensive human/virtual scribes. No having to remember what you prescribed. That is what they are trying to accomplish at DeepScribe. Learn more at deepscribe.tech
Vim, Inc. develops a healthcare platform to provide online services that helps patients and healthcare providers find, schedule, and receive care from doctors and specialists. It provides online booking solutions and referral coordination. The company was founded in 2015 and is based in San Francisco, California.
Pristyn Care is a healthcare startup focused on transforming day care procedures through advanced surgical care. Founded by former consultant surgeons from prestigious medical institutions and professionals from notable companies, Pristyn Care aims to streamline the patient experience by leveraging technology and innovative surgical techniques. The company offers a range of advanced laser surgeries in various specialties, including urology, proctology, ENT, gynecology, laparoscopy, and dermatology. By implementing efficient processes and utilizing cutting-edge advancements in healthcare, Pristyn Care seeks to enhance patient outcomes and facilitate quicker recovery times.
Miaoshou Doctor is a healthcare service platform founded in 2015 by Tao He and Daoliang Han, based in Beijing. The platform facilitates communication between healthcare professionals and patients, focusing on the management of post-diagnosis outcomes. It enables doctors to actively follow up with patients through additional counseling and prescriptions, enhancing the overall patient care experience. By providing tools for effective interaction, Miaoshou Doctor aims to improve health management for both patients and doctors.
WeDoctor Holdings (Zhejiang) Co., Ltd. is a prominent medical technology platform based in Hangzhou, China, founded in 2010. The company specializes in developing medical cloud and artificial intelligence solutions that cater to governments, hospitals, and healthcare institutions. WeDoctor provides a comprehensive cloud platform that facilitates both online and offline medical services, including general practice, specialty consultations, and appointment scheduling. Additionally, it operates a managed health services platform known as WeDoctor HMO, aimed at enhancing medical care accessibility and efficiency. By leveraging technology, WeDoctor strives to improve health management for users, positioning itself as a significant player in the health maintenance organization sector. Through its innovative approach, the company aims to serve as a crucial health resource for millions of families.
Smiles.ai leverages proprietary technology and expert healthcare professionals to provide access to high-quality and cost-effective dental care products and services.
Insight Lifetech Co., Ltd. is a Chinese company focused on the development and manufacturing of medical equipment for heart intervention. The firm specializes in creating high-quality devices designed to enhance the diagnosis and therapy of cardiovascular diseases. By utilizing innovative technologies, Insight Lifetech aims to provide reliable precision in medical treatments, ultimately enabling healthcare professionals to save and improve patients' lives.
dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.
Virta Health operates an online specialty medical clinic focused on reversing type 2 diabetes without the use of medications or surgery. Founded in 2014 and based in San Francisco, the company combines nutritional biochemistry, clinical expertise, data science, and digital tools to develop its treatment protocols. Through its continuous remote care platform, Virta provides medical and behavioral support to patients, resulting in significant health improvements. In clinical trials, 60% of participants achieved diabetes reversal within one year, and 94% of insulin users were able to reduce or eliminate their insulin usage. The benefits of Virta's treatment extend to other aspects of metabolic and cardiovascular health, demonstrating sustained improvements in blood pressure, inflammation, liver function, and body mass index (BMI).
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.
D3 Bio Inc. is a biotechnology company founded in 2020 and based in China. It specializes in the development and registration of innovative medicines, primarily focusing on oncology and immunology. The company adopts a unique approach to medicine development by first identifying significant unmet patient and market needs, particularly in areas where current treatments are inadequate. This understanding informs their research and guides the selection of appropriate scientific and technological methods to define their drug development strategy. Through this differentiated approach, D3 Bio aims to address critical health challenges and improve clinical outcomes for patients.
Pristyn Care is a healthcare startup focused on transforming day care procedures through advanced surgical care. Founded by former consultant surgeons from prestigious medical institutions and professionals from notable companies, Pristyn Care aims to streamline the patient experience by leveraging technology and innovative surgical techniques. The company offers a range of advanced laser surgeries in various specialties, including urology, proctology, ENT, gynecology, laparoscopy, and dermatology. By implementing efficient processes and utilizing cutting-edge advancements in healthcare, Pristyn Care seeks to enhance patient outcomes and facilitate quicker recovery times.
Biofourmis Singapore Pte. Ltd. is a digital therapeutics company that focuses on enhancing personalized care through innovative software-based solutions. Founded in 2015, it operates from its headquarters in Boston, Massachusetts, with additional offices in Singapore, Zurich, and Bengaluru. The company’s platform integrates artificial intelligence to analyze real-time physiological data from clinical-grade wearables, enabling healthcare professionals to detect patterns and predict medical events, such as heart failure and oncology-related issues. Its product offerings include BiovitalsHF for early heart failure detection, RhythmAnalytics for cardiac arrhythmia monitoring, and Painfocus for objective pain assessment, aimed at improving therapeutic decision-making. Additionally, Biofourmis provides Gaido for oncology patient monitoring and Biovitals Research, a digital trial platform that enhances patient engagement and data collection. Through these solutions, Biofourmis aims to facilitate better patient outcomes and cost-effective care for healthcare providers.
Dizal Pharmaceutical is a research-focused biotechnology company involved in the discovery, development, and commercialization of innovative medicines. The company specializes in creating first-in-class and best-in-class therapeutic solutions, emphasizing cutting-edge research and development. In addition to its drug development efforts, Dizal is also engaged in the production and sales of these innovative treatments, aiming to improve patient outcomes through advanced pharmaceutical solutions.
Practo Technologies Private Limited operates a comprehensive healthcare platform that connects patients with healthcare providers globally. Established in 2008 and headquartered in Bengaluru, India, Practo offers a range of services to meet diverse healthcare needs, including finding doctors, booking appointments, accessing online consultations, scheduling diagnostic tests, and ordering medicines. The platform also features Practo Ray, a subscription-based practice management software for healthcare professionals, and Practo Reach, a service that enhances visibility for hospitals and clinics. With additional offices in major Indian cities and locations in Southeast Asia and Brazil, Practo aims to facilitate better healthcare management by allowing users to store health records, consult doctors online, and engage with healthcare services more effectively.
AccuMedical
Series B in 2020
AccuMedical is a full-line product company in the field of neurological intervention, headquartered in Beijing with an R&D center located in California. It develops and produces medical device products for the treatment of aneurysms, preventing, and treating bleeding diseases caused by the rupture of vascular aneurysms.
Miaoshou Doctor is a healthcare service platform founded in 2015 by Tao He and Daoliang Han, based in Beijing. The platform facilitates communication between healthcare professionals and patients, focusing on the management of post-diagnosis outcomes. It enables doctors to actively follow up with patients through additional counseling and prescriptions, enhancing the overall patient care experience. By providing tools for effective interaction, Miaoshou Doctor aims to improve health management for both patients and doctors.
Healthlane is a healthcare technology company that operates an online application aimed at enhancing access to quality and affordable healthcare services in Africa. Established in 2020 and headquartered in Lagos, Nigeria, with additional offices in Yaounde, Cameroon, and San Francisco, California, the platform facilitates users in tracking medical appointments and consolidating their health data. It offers features such as virtual medical advice on various health topics, including pregnancy, vaccinations, lab results, family planning, and insurance records. By enabling direct communication with certified doctors, Healthlane empowers individuals to make informed health decisions and efficiently monitor their health status.
Virtual is a developer of prescription digital therapeutics platform intended to help mental health treatment. The company's tool adheres to strict compliance with FDA quality management standards and also is put through rigorous research trials and in certain cases is paired with existing pharmacological treatments, as well as uses virtual reality to administer VR exposure therapy, assign CBT assessments or exercises and track patient progress, enabling patients to overcome anxiety, phobia and obsessive-compulsive disorder easily.
Buymed operates a digital pharmaceuticals distribution platform in Vietnam, known as Thuocsi.vn. Founded in 2018 and based in Ho Chi Minh City, the platform supplies a wide range of healthcare products, including medicines, cosmetics, medical devices, and supplements. It serves over 1,000 pharmacies and clinics across the country, offering detailed product information such as pricing and active ingredients. Additionally, Thuocsi.vn features a communication network that provides important updates, including product recalls. The company is recognized as a successful startup in the medical technology sector, attracting young talent eager to integrate advanced technology into healthcare solutions.
MedGenome Labs Private Ltd. specializes in molecular genetic diagnostic testing, utilizing advanced technologies such as Sanger sequencing and next-generation sequencing to support personalized healthcare. The company offers a comprehensive range of genetic tests, including exome, whole genome, and mitochondrial genome sequencing, alongside various disease panels. These panels focus on hereditary cancers, somatic mutations in tumors, and genetic conditions affecting cardiac, eye, and neuromuscular health. Additionally, MedGenome provides targeted tests for genetic mutations linked to non-syndromic deafness and autism spectrum disorders. The company also maintains OncoMD, a database of cancer-related mutations sourced from peer-reviewed research. MedGenome's services are designed to guide clinicians in identifying appropriate treatment options based on genetic variations and assessing disease risk. Established in 2013 and headquartered in Chennai, India, MedGenome operates as a subsidiary of SciGenom Labs Pvt Ltd and collaborates strategically with Denali Therapeutics to enhance its research capabilities.
CERo Therapeutics, Inc. is a biotechnology company based in San Francisco, California, focused on advancing cellular immunotherapy. Established in 2016, the company has developed a hybrid platform that merges innate and adaptive immune responses to create engineered T-cell therapeutics for cancer treatment. This proprietary approach aims to harness the body's complete immune capabilities to enhance the effectiveness of cancer therapies. By integrating desirable features from both immune systems, CERo Therapeutics seeks to optimize treatment outcomes for patients with cancer.
Qure.ai Technologies Private Limited specializes in developing artificial intelligence software for the healthcare sector, focusing on medical imaging to enhance disease diagnosis from radiology and pathology images. Founded in 2016 and headquartered in Mumbai, India, with a presence in New York, the company offers tools such as qXR, which automates chest X-ray interpretation to identify abnormal findings, including signs of tuberculosis. Qure.ai also provides qER, which assists in triaging critical head CT scans and offers tools for monitoring traumatic brain injury and reporting. By leveraging deep learning solutions, Qure.ai aims to improve the accuracy of diagnoses and make healthcare more affordable and accessible, ultimately allowing healthcare professionals to dedicate more time to patient care.
Maven Clinic operates an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and postpartum stages. The clinic provides access to video appointments and private messaging with a network of women's and family health practitioners. Its services cover various needs, including IVF, egg freezing, pregnancy, postpartum support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and tailored training for human resources. The company serves individuals, employers, and healthcare professionals, aiming to enhance healthcare experiences and outcomes for families. Founded in 2014 and headquartered in New York City, Maven Clinic is dedicated to delivering accessible and comprehensive care solutions.
Maven Clinic operates an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and postpartum stages. The clinic provides access to video appointments and private messaging with a network of women's and family health practitioners. Its services cover various needs, including IVF, egg freezing, pregnancy, postpartum support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and tailored training for human resources. The company serves individuals, employers, and healthcare professionals, aiming to enhance healthcare experiences and outcomes for families. Founded in 2014 and headquartered in New York City, Maven Clinic is dedicated to delivering accessible and comprehensive care solutions.
Developer of dental imaging technology and dental clinic management software. The company's software helps dental professionals accurately diagnose patient conditions through oral CT scanning, as well as keep track of patient records and appointments, enabling dental professionals to provide treatment more efficiently.
Pristyn Care is a healthcare startup focused on transforming day care procedures through advanced surgical care. Founded by former consultant surgeons from prestigious medical institutions and professionals from notable companies, Pristyn Care aims to streamline the patient experience by leveraging technology and innovative surgical techniques. The company offers a range of advanced laser surgeries in various specialties, including urology, proctology, ENT, gynecology, laparoscopy, and dermatology. By implementing efficient processes and utilizing cutting-edge advancements in healthcare, Pristyn Care seeks to enhance patient outcomes and facilitate quicker recovery times.
Mosaic Wellness Pvt Ltd, founded in 2019 and based in Mumbai, India, operates a platform of digital-first health clinics aimed at enhancing the health and wellness of individuals. The company provides a range of health and wellness products through its online presence, focusing on personalized solutions for specific needs. Its brands, including ManMatters for men and BeBodywise for women, work collaboratively to promote a fulfilling and purposeful lifestyle. By addressing niche segments, Mosaic Wellness strives to empower individuals to lead healthier lives.
Migraine.AI is the first personalized migraine management application that can predict migraine attacks and optimize medication windows. Migraine.AI specialized in women's migraines. The app has tailored for the nuances a woman's body has, as well as many passive monitoring tools to monitor their health metrics.
Vim, Inc. develops a healthcare platform to provide online services that helps patients and healthcare providers find, schedule, and receive care from doctors and specialists. It provides online booking solutions and referral coordination. The company was founded in 2015 and is based in San Francisco, California.
HiFiBiO is a biotherapeutics company focused on harnessing the human immune system to address diseases, particularly cancer and autoimmune disorders. Founded in 2013 and based in Paris, the company specializes in proprietary single-cell technologies that facilitate drug and biomarker discovery and development. HiFiBiO's platform combines extensive biological knowledge with advanced single-cell profiling techniques, allowing for the rapid identification and advancement of antibody drugs. Through partnerships with both industry and academic institutions, HiFiBiO aims to promote open innovation and enhance patient outcomes by unlocking the therapeutic potential of the immune system.
Pristyn Care is a healthcare startup focused on transforming day care procedures through advanced surgical care. Founded by former consultant surgeons from prestigious medical institutions and professionals from notable companies, Pristyn Care aims to streamline the patient experience by leveraging technology and innovative surgical techniques. The company offers a range of advanced laser surgeries in various specialties, including urology, proctology, ENT, gynecology, laparoscopy, and dermatology. By implementing efficient processes and utilizing cutting-edge advancements in healthcare, Pristyn Care seeks to enhance patient outcomes and facilitate quicker recovery times.
1mg is a digital consumer healthcare platform based in Gurgaon, Haryana, India, launched in 2015. It aims to make healthcare more accessible, understandable, and affordable for users. The platform allows individuals to find detailed information about medicines prescribed by doctors and purchase them directly. Users can search for medications based on ailments, drug classes, companies, and brands. Additionally, 1mg features a doctor platform designed to help users locate suitable healthcare professionals for their needs. The company also offers a diagnostics service that enhances transparency and cost-effectiveness for lab tests, empowering Indian consumers and caregivers to choose the right healthcare services at competitive prices.
Biofourmis Singapore Pte. Ltd. is a digital therapeutics company that focuses on enhancing personalized care through innovative software-based solutions. Founded in 2015, it operates from its headquarters in Boston, Massachusetts, with additional offices in Singapore, Zurich, and Bengaluru. The company’s platform integrates artificial intelligence to analyze real-time physiological data from clinical-grade wearables, enabling healthcare professionals to detect patterns and predict medical events, such as heart failure and oncology-related issues. Its product offerings include BiovitalsHF for early heart failure detection, RhythmAnalytics for cardiac arrhythmia monitoring, and Painfocus for objective pain assessment, aimed at improving therapeutic decision-making. Additionally, Biofourmis provides Gaido for oncology patient monitoring and Biovitals Research, a digital trial platform that enhances patient engagement and data collection. Through these solutions, Biofourmis aims to facilitate better patient outcomes and cost-effective care for healthcare providers.
Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".
Medallia is a provider of customer and employee experience solutions through its SaaS platform, which captures experience data from various sources, including human, digital, and Internet of Things interactions. The platform employs artificial intelligence to analyze both structured and unstructured data, enabling organizations to gain insights into customer and employee sentiments. By utilizing the Medallia Experience Cloud, businesses can enhance customer retention, convert detractors into advocates, and identify real-time opportunities for cross-selling and upselling. Founded in 2001 and based in San Francisco, Medallia positions itself as a leader in customer experience and text analytics software, helping companies improve their operational performance and achieve significant returns on investment.
Athelas, Inc. develops and manufactures an innovative in-home blood diagnostic device designed to monitor the immune system using just a drop of blood. Founded in 2016 and based in Mountain View, California, the company's portable optical unit analyzes blood cells and generates diagnostic reports. This technology assists healthcare providers in early identification of conditions such as leukemia, infections, and inflammatory diseases, allowing patients to monitor their immunity levels conveniently from home. Athelas operates as a subsidiary of MerLion Pharmaceuticals Pte. Ltd.
Miaoshou Doctor is a healthcare service platform founded in 2015 by Tao He and Daoliang Han, based in Beijing. The platform facilitates communication between healthcare professionals and patients, focusing on the management of post-diagnosis outcomes. It enables doctors to actively follow up with patients through additional counseling and prescriptions, enhancing the overall patient care experience. By providing tools for effective interaction, Miaoshou Doctor aims to improve health management for both patients and doctors.
Phrase Health, Inc., founded in 2018 and based in Philadelphia, Pennsylvania, offers software solutions tailored for the healthcare sector. The company's platform is designed to help hospitals monitor and analyze the information provided to doctors and nurses at the point of care. By facilitating workflow management, Phrase Health enables healthcare professionals to identify actionable insights and supports data-driven process improvements. The software aids in decision-making and enhances user interaction, allowing for better coordination of strategic initiatives within healthcare environments.
Medtrum Technologies Inc. specializes in the development and delivery of medical devices for diabetes management. The company offers a range of products, including the A6 TouchCare System, a tubing-free semi-closed loop insulin management system that integrates an insulin patch pump and continuous glucose monitoring system (CGMS) with predictive low glucose suspend capabilities. Additionally, it provides the S6 EasySense disposable CGM system, which features a waterproof design and a hair-like sensor for real-time glucose monitoring over a week, and the P6 EasyPatch disposable pump that allows for adjustable basal rates and on-demand bolus delivery. Medtrum also incorporates a cloud-based healthcare system, featuring the EasyTouch mobile application and EasyView web portal, which enhances diabetes management by providing comprehensive data for patients, families, and healthcare providers. Founded in 2008 and headquartered in Shanghai, China, Medtrum operates in multiple locations, including Düsseldorf, Germany; Hong Kong; and Watford, United Kingdom.
VoxelCloud Inc. is a company that develops cloud computing and artificial intelligence solutions aimed at enhancing the analysis of medical images and clinical data for healthcare practitioners. Established in 2015 and headquartered in Los Angeles, California, VoxelCloud offers automated medical image analysis services designed to improve clinical workflows and deliver timely insights. The company's technology addresses various clinical needs, including the diagnosis of lung cancer, diabetic retinopathy, coronary heart disease, and liver disease. Utilizing proprietary algorithms and deep learning techniques, VoxelCloud provides accurate and personalized medical image analysis services. In addition to its Los Angeles headquarters, the company has offices in Shanghai and Suzhou, China, along with a satellite research and development team located in Phoenix.
Infervision is an artificial intelligence company based in Beijing that specializes in enhancing medical imaging diagnosis through deep learning and computer vision technologies. The company focuses on developing clinically valuable products aimed at improving the accuracy and efficiency of cancer diagnosis. Infervision has introduced innovative solutions such as the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT diagnostic products, which are currently undergoing trials at several prominent hospitals in China. The company collaborates closely with top institutions in radiology, fostering a strong relationship between medical science and technology. Infervision has partnered with approximately 20 leading hospitals, successfully integrating medical data and technology to advance healthcare solutions. By creating a unique artificial intelligence computing platform, Infervision aims to facilitate precise healthcare and improve diagnostic outcomes for medical professionals.
Genuity Science is a contract genomics and data-sourcing organization based in Boston, Massachusetts, with additional offices in Dublin, Ireland, and Reykjavik, Iceland. The company collaborates with global biopharma firms to provide comprehensive discovery services that enhance precision health and improve patient outcomes. Its offerings encompass population-scale, disease-specific data sourcing, high-quality sequencing, and advanced statistical analysis, along with software tools for managing large datasets and artificial intelligence applications. Genuity operates state-of-the-art CAP/CLIA genomics laboratories in Woburn, Massachusetts, and Dublin, emphasizing a strong commitment to data stewardship and governance. The company focuses on exploring biological data insights, storage, interpretation, and scalable analytics, particularly in the central nervous system, cardiometabolic, and inflammatory disease sectors.
Beijing Deep Intelligent Pharma Technology Co., Ltd. specializes in leveraging artificial intelligence and blockchain technology to enhance drug discovery, development, and medical affairs for pharmaceutical companies. Founded in 2017 and based in Beijing, the company offers a range of products, including a multi-language medical machine translation engine, intelligent pharmacovigilance for risk management, and tools for creating multilingual educational materials. Deep Intelligent Pharma also provides AI-enabled solutions for medical writing, document review, and quality control, as well as a patient search ecosystem to facilitate medical and clinical research. Additionally, the company offers intelligent regulatory affairs solutions to streamline drug research and development processes. Operating globally, including in China, the United States, and Japan, Deep Intelligent Pharma aims to improve the efficiency and quality of the pharmaceutical development lifecycle.
Maven Clinic operates an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and postpartum stages. The clinic provides access to video appointments and private messaging with a network of women's and family health practitioners. Its services cover various needs, including IVF, egg freezing, pregnancy, postpartum support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and tailored training for human resources. The company serves individuals, employers, and healthcare professionals, aiming to enhance healthcare experiences and outcomes for families. Founded in 2014 and headquartered in New York City, Maven Clinic is dedicated to delivering accessible and comprehensive care solutions.
DJ ChengYi
Series A in 2018
DJ ChengYi is an emotional and psychological interaction featured radio program.
Medlinker operates a social networking platform aimed at connecting verified doctors with their peers and various healthcare stakeholders. The platform facilitates easy communication and collaboration among certified medical professionals, allowing them to share knowledge, experiences, and insights. Key features include a medical quiz, case mapping, and anonymous social circles, all designed to enhance the exchange of high-quality information within the medical community. Additionally, Medlinker enables patients to book appointments and submit questions, fostering interaction between patients and healthcare providers. By streamlining referrals and the sharing of medical records, Medlinker seeks to improve access to essential medical information and enhance the overall efficiency of healthcare delivery.
Farcast is a clinical diagnostic company dedicated to providing personalized cancer treatment solutions. Its core technology utilizes a human tumor microenvironment to enable oncologists and drug developers to assess individual tumors and determine their treatment response profiles. This innovative approach aims to surpass traditional biomarker-guided strategies, thereby enhancing access to personalized medicine and improving the clinical management of cancer. Headquartered in Boston, Massachusetts, Farcast also operates a laboratory in Bangalore, India, reflecting its commitment to advancing cancer care through cutting-edge technology.
Brii Biosciences is a developer of bio-pharmaceutical medicines intended to provide medical solutions to Chinese patients to fulfill their health and treatment needs. The company's medicines focuses on infectious disease drug development and commercialization in China and leverage technology and data to drive improvements to the Chinese healthcare system and outcomes for patients, enabling patients to get access to better treatments and cures for life-threatening diseases.
Grail, Inc. is a healthcare company dedicated to developing innovative technologies for early cancer detection. Founded in 2015 and based in Menlo Park, California, the company has created Galleri, a blood test designed for asymptomatic individuals over 50 years old, which identifies various types of cancer at early stages. In addition to Galleri, Grail is developing a diagnostic aid called DAC to accelerate the diagnostic process for patients with a clinical suspicion of cancer. The company is also working on tests for minimal residual disease and other post-diagnostic applications. Through high-intensity sequencing and population-scale clinical trials, Grail aims to advance the field of cancer screening and improve patient outcomes.
Decent Inc. is a healthcare insurance provider based in Mill Valley, California, founded in 2018. The company specializes in offering health and medical insurance plans tailored for self-employed professionals, notably the Trailblazer Plan, which is designed to meet the unique needs of freelance workers. Decent aims to make healthcare more affordable by aligning incentives to enhance health outcomes and lower costs. Utilizing innovative technologies such as cryptocurrency and blockchain, Decent's platform facilitates access to a range of insurance options while partnering with a network of healthcare providers, including doctors, hospitals, and specialists. This approach places members at the center of their care, promoting better health management and financial savings.
HiFiBiO is a biotherapeutics company focused on harnessing the human immune system to address diseases, particularly cancer and autoimmune disorders. Founded in 2013 and based in Paris, the company specializes in proprietary single-cell technologies that facilitate drug and biomarker discovery and development. HiFiBiO's platform combines extensive biological knowledge with advanced single-cell profiling techniques, allowing for the rapid identification and advancement of antibody drugs. Through partnerships with both industry and academic institutions, HiFiBiO aims to promote open innovation and enhance patient outcomes by unlocking the therapeutic potential of the immune system.
MabSpace Biosciences, is a biotech company focused on discovery and development of innovative antibody based therapeutics for cancer and fibrotic diseases. It was founded in 2013 by indrustrial veterans and is located in Biobay Suzhou, an emerging bitech incubator in China. MabSpace employes its proprietary platform technology, immune tolerance breaking technology (IMBT), to generate lead antibodies with diverse epitopes. MabSpace has established multiple antibody discovery and co-development partnerships based on this technology. MabSpace raised 15 million USD from Lilly Asia Ventures in 2015 to advance its lead antibody program, a potentially best-in-class anti-PD-L1 antibody with unique pH-dependent binding and recycling property and significantly improved efficacy in animal models. It has also built a panel of 2nd generation immuno-oncology antibodies targeting different components of the tumor microenvironment,which enables the testing of combination therapeutic interventions with its PD-L1 antibody.
The Senyi team is composed of elites from well-known universities and well-known companies at home and abroad. It integrates experts in areas such as artificial intelligence, medicine, medical informatics, and medical informationization. The core team's technical achievements have been applied to a number of national and municipal projects. He has published more than 20 papers in international top journals and has spoken at top international medical conferences.
Miaoshou Doctor is a healthcare service platform founded in 2015 by Tao He and Daoliang Han, based in Beijing. The platform facilitates communication between healthcare professionals and patients, focusing on the management of post-diagnosis outcomes. It enables doctors to actively follow up with patients through additional counseling and prescriptions, enhancing the overall patient care experience. By providing tools for effective interaction, Miaoshou Doctor aims to improve health management for both patients and doctors.
Infervision is an artificial intelligence company based in Beijing that specializes in enhancing medical imaging diagnosis through deep learning and computer vision technologies. The company focuses on developing clinically valuable products aimed at improving the accuracy and efficiency of cancer diagnosis. Infervision has introduced innovative solutions such as the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT diagnostic products, which are currently undergoing trials at several prominent hospitals in China. The company collaborates closely with top institutions in radiology, fostering a strong relationship between medical science and technology. Infervision has partnered with approximately 20 leading hospitals, successfully integrating medical data and technology to advance healthcare solutions. By creating a unique artificial intelligence computing platform, Infervision aims to facilitate precise healthcare and improve diagnostic outcomes for medical professionals.
Moderna, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2010. It specializes in the development of therapeutics and vaccines utilizing messenger RNA technology, which instructs cells to produce proteins essential for various biological functions. The company's extensive pipeline includes 40 mRNA development candidates targeting a range of therapeutic areas such as infectious diseases, oncology, cardiovascular diseases, and rare genetic disorders. Moderna gained significant recognition with its COVID-19 vaccine, which was authorized for use in the United States in December 2020. The company maintains strategic partnerships with organizations such as AstraZeneca, Merck & Co., and the Bill & Melinda Gates Foundation, enhancing its research capabilities and manufacturing processes. Additionally, it has research collaborations with esteemed institutions like Harvard University.
Medlinker operates a social networking platform aimed at connecting verified doctors with their peers and various healthcare stakeholders. The platform facilitates easy communication and collaboration among certified medical professionals, allowing them to share knowledge, experiences, and insights. Key features include a medical quiz, case mapping, and anonymous social circles, all designed to enhance the exchange of high-quality information within the medical community. Additionally, Medlinker enables patients to book appointments and submit questions, fostering interaction between patients and healthcare providers. By streamlining referrals and the sharing of medical records, Medlinker seeks to improve access to essential medical information and enhance the overall efficiency of healthcare delivery.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.